Pfizer sues to block Watson's Embeda copy; Celesia snaps up 60% of Brazil's Oncoprod;

@FiercePharma: From NYT, a Q&A with Novartis chief Joe Jimenez, including how he learned to welcome bad news Story | Follow @FiercePharma

> Pfizer ($PFE) sued Watson Pharmaceuticals after the generics maker asked FDA to approve its version of the pain drug Embeda, which Pfizer acquired in its deal for King Pharmaceuticals. Article

> German drug distributor Celesio bought a 60% stake in Brazil's specialty pharma wholesaler Oncoprod Group, which expects €350 million in revenue this year. Report

> India's prime minister was scheduled to meet today with three government ministers to discuss discord over proposed restrictions on foreign investment in the pharma sector. Story

> Novo Nordisk ($NVO) launched its diabetes drug Victoza in China, one of the fastest-growing diabetes markets in the world. Report

> Counterfeit drugs estimated to be a $75 billion global business. Report

> Patients in Jamaica are stockpiling their own drugs for resale, the Pharmaceutical Society of Jamaica tells Parliament. Article

> Teva Pharmaceutical Industries ($TEVA) launched an infant formula, Nutrilon, in Israel, at a 5% to 10% discount off competing brands. Story

> Milan Puskar, co-founder and former chairman of generics maker Mylan, died Friday at the age of 77. Report

Biotech News

@FierceBiotech: Mobile tech veteran Chris Toumazou pioneers DNA analysis methods. Article | Follow @FierceBiotech

@ JohnCFierce: Third Rock seeds a new approach to treating diabetes and obesity. Item | Follow @JohnCFierce

@RyanMFierce: Do niche EDC players stand a chance? This Dublin upstart has found its sweet spot with EDC for post-market apps Report | Follow @RyanMFierce

@MaureenFierce: CA passes law that removes parental consent for vaccinating kids 12 and older against STDs. More | Follow @MaureenFierce

> Pfizer stem cell study highlights sea change for a controversial field. Story

> Third Rock seeds a new approach to treating diabetes and obesity. News

Medical Device News

> MAKO aims to get hip-replacement patients back on feet faster. Piece

> Axis-Shield accepts increased Alere offer. Report

> FDA, CMS launch parallel review pilot. Item

> AngioDynamics sees net income fall in Q1. Article

> Ex-Medtronic CEO Hawkins to head Immucor. Report

Biotech IT News

> Mobile tech vet pioneers DNA analysis methods. Story

> Honoring bioinformatics pioneer on Ada Lovelace Day. More

> EDC upstart CTEP tackles Ph4 market. Article

> Software models response to H. pylori. Item

> Eric Schadt leading biotech computing charge in NYC. More

> Kansas U. nails bioinformatics faculty members for part in plagiarism. News

And Finally... Greece's economic woes are taking their toll on people's health, with HIV and drug abuse rising. Article